Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-28 @ 7:09 AM
Study NCT ID:
NCT00589550
Status:
TERMINATED
Last Update Posted:
2015-06-08
First Post:
2008-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Sponsor:
Thomas Olencki
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-05
First Submit QC Date:
None
Study First Post Date:
2008-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-06
Results First Submit QC Date:
None
Results First Post Date:
2015-06-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-04
Last Update Post Date:
2015-06-08
Last Update Post Date Type:
ESTIMATED